Kuno-Sakai H - Search Results

1

Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin.

Ginnaga A, Morokuma K, Aihara K, Sakou M, Imaizumi A, Suzuki Y, Sato H, Sato Y, Ueda K, Kuno-Sakai H, et al. Ginnaga A, et al. Tokai J Exp Clin Med. 1988;13 Suppl:59-69. Tokai J Exp Clin Med. 1988. PMID: 2908528 Clinical Trial.

2

Immunogenicity and reactogenicity of the component acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous haemagglutinin.

Kimura M, Kuno-Sakai H, Kamiya H, Ueda K, Isomura S, Koike M, Kato T, Ozaki T, Hirose M, Egami T. Kimura M, et al. Among authors: kuno sakai h. Acta Paediatr Jpn. 1995 Oct;37(5):562-74. doi: 10.1111/j.1442-200x.1995.tb03378.x. Acta Paediatr Jpn. 1995. PMID: 8533580 Clinical Trial.

3

Japanese clinical trials with Takeda acellular pertussis vaccine.

Kuno-Sakai H, Kimura M, Ozaki K, Isomura S, Kamiya H, Nii R, Kato T, Horiuchi K, Syukuda Y, Fujita I, et al. Kuno-Sakai H, et al. Tokai J Exp Clin Med. 1988;13 Suppl:15-9. Tokai J Exp Clin Med. 1988. PMID: 2908519 Clinical Trial.

4

Serum anti-PT and anti-FHA antibody levels, and agglutinin titers after administration of acellular pertussis vaccines.

Kuno-Sakai H, Kimura M, Sato Y, Tsunoda A, Urano T, Isomura S, Kamiya H. Kuno-Sakai H, et al. Acta Paediatr Jpn. 1989 Apr;31(2):120-6. doi: 10.1111/j.1442-200x.1989.tb01277.x. Acta Paediatr Jpn. 1989. PMID: 2516691

5

Experiences with acellular pertussis vaccine in Japan and epidemiology of pertussis.

Kimura M, Kuno-Sakai H. Kimura M, et al. Tokai J Exp Clin Med. 1987 Dec;12(5-6):263-73. Tokai J Exp Clin Med. 1987. PMID: 3508651

6

Aerosol infection test for evaluation of pertussis vaccine.

Syukuda Y, Watanabe H, Suehara A, Fujii S, Kuno-Sakai H, Kimura M. Syukuda Y, et al. Tokai J Exp Clin Med. 1988;13 Suppl:71-7. Tokai J Exp Clin Med. 1988. PMID: 2908529

7

[Epidemiology of pertussis and studies on culture positive pertussis cases in Japan].

Kimura M, Kuno-Sakai H, Kunita N, Isomura S, Funahashi M, Sato Y. Kimura M, et al. Among authors: kuno sakai h. Kansenshogaku Zasshi. 1996 Jan;70(1):19-28. doi: 10.11150/kansenshogakuzasshi1970.70.19. Kansenshogaku Zasshi. 1996. PMID: 8822050 Japanese.

8

A comparative trial of the reactogenicity and immunogenicity of Takeda acellular pertussis vaccine combined with tetanus and diphtheria toxoids. Outcome in 3- to 8-month-old infants, 9- to 23-month-old infants and children, and 24- to 30-month-old children.

Kimura M, Kuno-Sakai H, Sato Y, Kamiya H, Nii R, Isomura S, Horiuchi K, Kato T, Deguchi M, Saikusa H, et al. Kimura M, et al. Am J Dis Child. 1991 Jul;145(7):734-41. Am J Dis Child. 1991. PMID: 2058603

9

Epidemiology of pertussis in Japan.

Kimura M, Kuno-Sakai H. Kimura M, et al. Tokai J Exp Clin Med. 1988;13 Suppl:1-7. Tokai J Exp Clin Med. 1988. PMID: 3273609 No abstract available.

10

Pertussis vaccine acceptance rates and incidence of pertussis in forty seven districts (prefectures) in Japan since 1977.

Kimura M, Kuno-Sakai H, Ozaki K. Kimura M, et al. Tokai J Exp Clin Med. 1988;13 Suppl:9-13. Tokai J Exp Clin Med. 1988. PMID: 3273621 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters